🇺🇸 FDA
Pipeline program

CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule, TOCILIZUMAB

APHP220797

Phase 3 small_molecule active

Quick answer

CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule, TOCILIZUMAB for Sickle cell disease is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Sickle cell disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials